BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10365963)

  • 1. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA.
    Lee D; Sohn H; Kalpana GV; Choe J
    Nature; 1999 Jun; 399(6735):487-91. PubMed ID: 10365963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hSNF5 is required for human papillomavirus E2-driven transcriptional activation and DNA replication.
    Cha S; Seo T
    Intervirology; 2011 Feb; 54(2):66-77. PubMed ID: 20829602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
    Wu DY; Kalpana GV; Goff SP; Schubach WH
    J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA replication specificity and functional E2 interaction of the E1 proteins of human papillomavirus types 1a and 18 are determined by their carboxyl-terminal halves.
    Gopalakrishnan V; Sheahan L; Khan SA
    Virology; 1999 Apr; 256(2):330-9. PubMed ID: 10191198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrase interactor 1 in health and disease.
    Das S
    Curr Protein Pept Sci; 2015; 16(6):478-90. PubMed ID: 25772157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions.
    Cooper CS; Upmeyer SN; Winokur PL
    Virology; 1998 Feb; 241(2):312-22. PubMed ID: 9499806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human SNF5/INI1 protein facilitates the function of the growth arrest and DNA damage-inducible protein (GADD34) and modulates GADD34-bound protein phosphatase-1 activity.
    Wu DY; Tkachuck DC; Roberson RS; Schubach WH
    J Biol Chem; 2002 Aug; 277(31):27706-15. PubMed ID: 12016208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin remodeling factor encoded by ini1 induces G1 arrest and apoptosis in ini1-deficient cells.
    Ae K; Kobayashi N; Sakuma R; Ogata T; Kuroda H; Kawaguchi N; Shinomiya K; Kitamura Y
    Oncogene; 2002 May; 21(20):3112-20. PubMed ID: 12082626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia.
    Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC
    Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle.
    Versteege I; Medjkane S; Rouillard D; Delattre O
    Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.
    Zhang ZK; Davies KP; Allen J; Zhu L; Pestell RG; Zagzag D; Kalpana GV
    Mol Cell Biol; 2002 Aug; 22(16):5975-88. PubMed ID: 12138206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of domains of the HPV11 E1 protein required for DNA replication in vitro.
    Amin AA; Titolo S; Pelletier A; Fink D; Cordingley MG; Archambault J
    Virology; 2000 Jun; 272(1):137-50. PubMed ID: 10873756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a monoclonal antibody for INI1/hSNF5/BAF47.
    Harada A; Hayashi M; Kuniyoshi Y; Semba Y; Sugahara S; Tachibana T; Ohkawa Y; Fujita M
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):49-51. PubMed ID: 24555937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation analyses suggest species-specific functions of the SNF5 homology domain.
    Bonazzi V; Medjkane S; Quignon F; Delattre O
    Biochem Biophys Res Commun; 2005 Oct; 336(2):634-8. PubMed ID: 16154112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis.
    Craig E; Zhang ZK; Davies KP; Kalpana GV
    EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication.
    Zou N; Liu JS; Kuo SR; Broker TR; Chow LT
    J Virol; 1998 Apr; 72(4):3436-41. PubMed ID: 9525677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization.
    Medjkane S; Novikov E; Versteege I; Delattre O
    Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.